Effect of moxibustion on ureteral stent-related symptoms after ureteroscopic lithotripsy.
10.13703/j.0255-2930.20230422-k0001
- Author:
Hao CHEN
1
;
Yun WANG
1
;
Zhi-Min WANG
1
;
Yu ZHANG
1
;
Run-Pu ZHAO
2
Author Information
1. Graduate School of Henan University of CM, Zhengzhou 450046, China.
2. Urology Department of First Affiliated Hospital of Henan University of CM, Zhengzhou 450099. zhaorunpu1219@163.com.
- Publication Type:Journal Article
- Keywords:
moxibustion;
placebo moxibustion;
randomized controlled trial (RCT);
tamsulosin;
ureteral stent-related symptoms;
ureteroscopic lithotripsy
- MeSH:
Humans;
Ureteroscopy/adverse effects*;
Moxibustion;
Lithotripsy/adverse effects*;
Pain;
Lower Urinary Tract Symptoms;
Calculi;
Stents/adverse effects*;
Acupuncture Points
- From:
Chinese Acupuncture & Moxibustion
2023;43(11):1251-1256
- CountryChina
- Language:English
-
Abstract:
OBJECTIVES:To observe the clinical efficacy of moxibustion combined with western medication on ureteral stent-related symptoms after ureteroscopic lithotripsy (URL).
METHODS:One hundred and fifty patients with upper urinary tract calculus implanted with ureteral stents after URL were randomly divided into a moxibustion group (50 cases, 1 case dropped out), a placebo moxibustion group (50 cases, 3 cases dropped out) and a blank control group (50 cases). No intervention was performed in the blank control group. On the basis of oral administration with tamsulosin hydrochloride sustained release capsule (starting from the first day after surgery, once a day, 0.2 mg each time, continuously for 4 weeks), in the moxibustion group, moxibustion was operated at Guanyuan (CV 4) and bilateral Shenshu (BL 23); the sham-moxibustion was delivered at the same acupoints in the placebo moxibustion group, once daily, 6 times a week, for 15 min in each treatment. The duration of treatment was 4 weeks. Before treatment, and after 1, 2 and 4 weeks of treatment, the scores of lower urinary tract symptoms, body pain, general health, work performance and satisfaction of sexual matters were compared among the 3 groups. The tract calculus clearance rate, urinary infection and the oral administration of painkillers were compared after 4 weeks of treatment in the 3 groups.
RESULTS:The scores of lower urinary tract symptoms, body pain and general health after 1 week of treatment, and the scores of lower urinary tract symptoms, body pain, general health and work performance after 2 and 4 weeks of treatment were lower than those before treatment in the 3 groups (P<0.01). The scores of lower urinary tract symptoms and body pain in the moxibustion group after 1, 2 and 4 weeks of treatment were lower than those in the blank control group and the placebo moxibustion group (P<0.01, P<0.05) respectively. The score of general health in the moxibustion group was lower than that in the blank control group after 1 week of treatment (P<0.01), and lower than those of the blank control group and the placebo moxibustion group after 2 and 4 weeks of treatment (P<0.01, P<0.05). Regarding the score of work performance, it was lower in the moxibustion group after 1 and 2 weeks of treatment compared with those in the blank control group (P<0.05, P<0.01), and lower than those of the blank control group and the placebo moxibustion group after 4 weeks of treatment (P<0.01, P<0.05). The tract calculus clearance rate in the moxibustion group was 95.9% (47/49), higher than that in the blank control group (80.0%, 40/50, P<0.05). The proportion of oral administration of painkillers in the moxibustion group (28.6%, 14/49) and the placebo moxibustion group (40.4%, 19/47) was lower than that in the blank control group (76.0%, 38/50, P<0.01) respectively.
CONCLUSIONS:Moxibustion combined with western medication relieves lower urinary tract symptoms and body pain, and accelerate the recovery of general health and work performance in the patients after URL.
